FDA Questions Safety Of J&J, Bayer's Xarelto
Voicing concerns about the effectiveness and safety of Johnson & Johnson and Bayer HealthCare LLC's blood thinner Xarelto, U.S. Food and Drug Administration staff declined to recommend approval for the drug...To view the full article, register now.
Already a subscriber? Click here to view full article